mynth
05/2026100%

Aleris acquired by Mehiläinen Group

SWEDEN Health Providers / Healthcare Facilities / Clinics / Hospitals REV SEK 1–10bn

Context

Mehiläinen Group acquired 100% of Aleris Group from Triton Partners in a transformational pan-European healthcare transaction. The deal was structured via a definitive share purchase agreement that pooled institutional equity from Mehiläinen's financial sponsors, CVC Capital Partners and Hellman & Friedman, alongside tailored cross-border corporate debt facilities. While the exact financial terms of the purchase price remained undisclosed, the transaction successfully integrated Aleris into Mehiläinen’s international operations as a distinct, specialized care platform. Under the binding terms of the agreement, Aleris Group CEO Sofia Palmquist retains her operational leadership role to ensure regional business continuity alongside Mehiläinen Group CEO Janne-Olli Järvenpää. This acquisition immediately expands Mehiläinen’s Scandinavian footprint into Norway and Denmark while drastically scaling its existing Swedish Meliva brand, creating a combined healthcare powerhouse with 60,000 professionals across 1,500 locations positioned to deliver highly integrated, digitally powered outpatient care pathways across Europe.

In the past, Aleris was acquired by Triton Partners in 2019 as part of its expansion strategy.

Aleris, which reported an EBITDA margin of [members only] in 2025, is valued in this transaction at an EV/EBITDA multiple of [members only].

-> Deep-dive in Healthcare & Pharma market trends

Target

Aleris Group is a premier Scandinavian healthcare provider specializing in high-quality elective surgery, outpatient mental health services, and medical diagnostics. Headquartered in Stockholm, Sweden, the company operates via a multi-payer economic model, serving roughly millions patient visits annually through public healthcare system allocations, private health insurance programs, and out-of-pocket direct payments. The organization runs a unified network of approximately +100 clinics and hospitals staffed by +5,000 specialized medical professionals across Sweden, Norway, and Denmark. Strategically, the firm acts as a dominant, high-equity clinical complement to publicly funded healthcare systems, utilizing advanced digital infrastructure to streamline outpatient care pathways.

Ent. Value

[members only]

Equity Value

[members only]

Multiples

EV / Revenue

[members only]

EV / EBITDA

[members only]

EV / EBIT

[members only]

Historical Financials (SEK)

Year
Rev
EBITDA
EBIT
2025
SEK 1–10bn
[members only]
[members only]
2024
SEK 1–10bn
[members only]
[members only]

Other operations with Aleris

Other operations with Aleris
DateAcquirerTargetCountrySector
07/2019TRITON PARTNERSALERISSWEDENClinics / Hospitals

Similar deals in Health Providers

Similar deals in Health Providers
DateAcquirerTargetCountrySector
09/2026BRIDGEPOINTALTANOGERMANYVet Clinics
06/2026STAR CAPITALGLENHOLME SPECIALIST CAREUNITED KINGDOMNursing Homes
05/2026KINDERHOOK INDUSTRIESENHABITUNITED STATESClinics / Hospitals
05/2026STONEPEAKESTIA HEALTHAUSTRALIANursing Homes
05/2026JARDINE MATHESONI-MED RADIOLOGY NETWORKAUSTRALIARadiology
04/2026COLOSSEUM DENTAL GROUPMEDICALSANITALYDental Centers
03/2026CAPITONSAPV CAREGERMANYOutpatient Care
02/2026MERIEUX EQUITY PARTNERSHEALTH IN CODE (HIC)SPAINLabs (Biology)
01/2026GTCRDENTALCORPCANADADental Centers
01/2026POINT VISIONCLINIQUE DE LA VISION (REFRACT SAS)FRANCEOphthalmology

REFERENCES

Revenue range: REV SEK 1–10bn

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Aleris by Mehiläinen Group are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

FAQ

What transaction does this page cover?

This page covers Mehiläinen Group’s acquisition of 100% of Aleris, a Swedish company specialised in Healthcare Facilities, in 2026. This followed an earlier holding cycle initiated in July 2019, when the company was acquired by Triton Partners.

What was Aleris’s revenue at the time of the deal?

At the time of the transaction, Aleris’s annual revenue was estimated within the SEK 1–10bn range (FY 2025). Detailed financial figures are available to members.

What sources support the information on this transaction?

Transaction data and operational intelligence were compiled from independent financial press reporting by specialized M&A publications.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.